Broadens our base of interested parties also:
“We are particularly pleased by the support from new institutional investors as they take the opportunity to join Botanix on its journey towards FDA approval and commercialisation of our lead product, Sofpironium Bromide for primary axillary hyperhidrosis.”
Ann: Botanix Raises A$10 million via Institutional Placement, page-22
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55151 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 09.53am 19/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
Day chart unavailable